Belite Bio (BLTE) Non Operating Income (2022 - 2026)
Belite Bio (BLTE) recorded Non Operating Income of $6.55 million in Q2 2026, up 413.3% from $1.28 million a year earlier and up 14.0% from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Non Operating Income (2022 - 2026) Analysis & Trends
On a TTM basis, Belite Bio's Non Operating Income came in at $13.62 million as of Jun 30, 2026, up 280.9% year-over-year; for FY2025, it came in at $6.6 million, up 71.0% from FY2024.
- Across earlier years, Non Operating Income came in at $3.86 million in FY2024, $45,000 in FY2023 (-74.0%), $173,000 in FY2022 (+32.1%) and $131,000 in FY2021.
- The Q2 2026 figure is the highest quarterly Non Operating Income in data going back to Q1 2022.
- On a year-over-year basis, Non Operating Income has increased for six consecutive quarters, with growth averaging 183.9% over the last six quarters.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 413.3% in Q2 2026, against a decline of 100.0% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.75 million (Q1 2026), $27.53 (Q4 2025) and $1.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Belite Bio | 6.16 Bn | 6.16 Bn | - | 6.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.55 Mn |
| Mar 31, 2026 | 5.75 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 977,000.00 |
| Mar 31, 2024 | 463,000.00 |
| Dec 31, 2023 | -36,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Dec 31, 2022 | -62,000.00 |
| Sep 30, 2022 | 137,000.00 |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | -17,000.00 |
API Access
Belite Bio Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();